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 The three ‘New Tools ’ working groups are sometimes referred to as research groups. 
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Please rate the level of communication… 
Answer Options Between WG/SGs  
Between WG/SGs & 
Coordinating Board 
Between WG/SGs & 
Partnership Secretariat 
Frequent 9.4% 3.8% 15.6% 
Periodic 24.4% 25.6% 25.% 
Limited 33.8% 28.8% 24.4% 
Very limited 20.6% 16.3% 9.4% 














 According to the Stop TB website “The Partners' Forum is the assembly of the Stop TB Partnership and consists of 
an inclusive, consultative meeting of representatives of all the Partners. In addition, all who have an interest in helping 















































































Question 18: What are the main ways in which your working group (or sub-group) currently reviews & evaluates its progress? 
Select no more than three. 
Answer Options Response Percent Response Count 
Agenda item for discussion in meetings 54.1% 79 
Surveys/questionnaires 26.0% 38 
Report to the Partners Forum and/or 
Coordinating Board 
33.6% 49 
Annual review & report for internal use 38.4% 56 
Annual review & report for external use 14.4% 21 
Review by Stop TB Secretariat 18.5% 27 
Independent external evaluation 8.2% 12 
My working group (or sub-group) does 19.2% 28 
23 
 
not currently review & evaluate progress 
Other (please specify) 25  
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Question 2: Your Organizational Type: 
Answer Options Response Percent Response Count 
Academic / Research Institution 10.6% 17 
Foundation 4.4% 7 
Governmental Organization 8.8% 14 
Multilateral Organization 3.1% 5 
NGO  59.4% 95 
Partnership 2.5% 4 
Patient Organization  3.8% 6 
Private Sector 3.1% 5 
Other (Please specify) 4.4% 7 
Other (please specify) 11 
answered question 160 
 
Question 3: Please indicate which working group you most actively part icipate in 
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(select one choice only) 




DOTS Expansion 25.6% 41 
TB/HIV 33.1% 53 
MDR-TB 5.6% 9 
Global Laboratory Initiative 3.8% 6 
New TB Diagnostics 5.0% 8 
New TB Drugs 4.4% 7 
New TB Vaccines 12.5% 20 
I do not directly participate in Working Groups 10.0% 16 
answered question 160 
  
Question 4: Please indicate the sub-groups and/or task forces in which you 
part icipate (t ick al l  that apply).  




DOTS Expansion: Advocacy, Communication & Social 
Mobilization (ACSM) subgroup 
47.5% 76 
DOTS Expansion: Childhood TB subgroup 11.3% 18 
DOTS Expansion: Human Resources Development (HRD) 
subgroup 
12.5% 20 
DOTS Expansion: Introduction of New Approaches and 
Technologies (INAT) subgroup 
9.4% 15 
DOTS Expansion: Public Private Mix (PPM) subgroup 16.3% 26 
DOTS Expansion: TB & Poverty subgroup 16.9% 27 
TB/HIV: Infection Control subgroup 26.9% 43 
MDR-TB: Global Green Light Committee (gGLC) 6.3% 10 
MDR-TB: Research subgroup 8.1% 13 
Global Laboratory Initiative: TB Supranational Reference 




New TB Diagnostics: Drug Susceptibility subgroup 7.5% 12 
New TB Diagnostics: Diagnostics for Latent TB infection 
subgroup 
5.6% 9 
New TB Diagnostics: Point-of-Care diagnostics for TB 
subgroup 
5.6% 9 
New TB Diagnostics: Evidence Synthesis and Policy 
subgroup 
2.5% 4 
New TB Diagnostics: Community, Poverty & Advocacy 
subgroup 
15.0% 24 
New TB Diagnostics: Pediatric TB subgroup 3.8% 6 
New TB Drugs: Biology Targets subgroup 2.5% 4 
New TB Drugs: Candidates subgroup 4.4% 7 
New TB Drugs: Critical Knowledge & Tools subgroup 6.3% 10 
New TB Drugs: Clinical Trials Capacity subgroup 6.3% 10 
New TB Vaccines: Harmonization of Assays for TB Vaccine 
Development Task Force 
4.4% 7 
New TB Vaccines: Clinical Research Issues in TB Vaccine 
Development Task Force 
8.1% 13 
New TB Vaccines: New Approaches to TB Vaccine 
Development Task Force 
4.4% 7 
New TB Vaccines: Economics & Product Profiles for New 
TB Vaccines Task Force 
3.1% 5 
New TB Vaccines: Advocacy, Communications & Social 
Mobilization Task Force 
11.3% 18 
I do not participate in any sub-group 10.6% 17 
answered question 160 
 
Question 6: To what extent do you think the goals of your working group (or sub-
group) are appropriately defined? Refer to the WG websites i f  unfamil iar with 
goals. 




Well-defined 51.3% 82 
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Somewhat defined 35.6% 57 
Vaguely defined 6.9% 11 
Undefined 0.6% 1 
Do not know 5.6% 9 
Please explain 52 











Question 7: The objectives of the Global Plan to Stop TB are to:  -  Achieve 
universal access to high-quali ty care for al l  people with TB  - Reduce the human 
suffering and socioeconomic burden associated with TB  - Protect vulnerable 
populations from TB, TB/HIV and drug-resistant TB  - Support development of new 
tools and enable their t imely and effective use  -  Protect and promote human 
rights in TB prevention, care and control   To what extent is your working group 
(or sub-group) helping to achieve these objectives? 




Not at all 2.5% 4 
To a small extent 6.3% 10 
To some extent 17.5% 28 
To a moderate extent 23.8% 38 
To a great extent 33.1% 53 
To a very great extent 16.9% 27 
Please explain 69 













Question 8: To what extent are partner roles & responsibi l i t ies clearly defined in 
your working group (or sub-group)? 




Not at all 3.8% 6 
To a small extent 13.1% 21 
To some extent 22.5% 36 
To a moderate extent 25.6% 41 
To a great extent 30.6% 49 
To a very extent 4.4% 7 
Please explain  53 









Question 9: How frequently does your working group (or sub-group) meet (both in 
person or via teleconference)?  




Much too often 6.9% 11 
A little to often 16.3% 26 
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Just about right 39.4% 63 
Not often enough 28.8% 46 
Hardy at all 8.8% 14 
Any specific changes you would make to the frequency? 54 














Question 10: Which of the fol lowing aspects of your meetings need improvement? 
(select al l  that apply) 




Agenda setting 24.4% 39 
Facilitation & process 48.1% 77 
Partner attendance & participation 59.4% 95 
Documenting and distributing minutes & action points 35.0% 56 
Other (please specify) 41 



















Question 11: How would you characterize the representation from the fol lowing 
















10 83 31 11 135 
Foundation 5 63 37 16 121 
Governmental 
Organization 
7 69 50 11 137 
Multilateral 
Organization 
3 57 45 18 123 
NGO 10 97 34 6 147 
Partnership 2 85 24 12 123 
Patient 
Organization 
3 51 46 26 126 
Private Sector 3 45 56 23 127 
Please identify any other actors that should be represented? 32 




Question 12: To what extent are you aware of the actual distr ibution of funds 
among different working groups?   




Not at all 40.0% 64 
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To a small extent 21.3% 34 
To some extent 16.9% 27 
To a moderate extent 11.9% 19 
To a great extent 6.3% 10 
To a very extent 3.8% 6 
answered question 160 
It was clear in the comments section that very few people knew anything about how funds were distributed 
amongst WGs/SGs. Many questioned the process for allocating funds. 
Question 13: How satisf ied are you with the current distr ibution of funds among 
working groups? 




Extremely dissatisfied 18.8% 30 
Dissatisfied 29.4% 47 
Moderately satisfied 45.0% 72 
Extremely satisfied 6.9% 11 
Please explain 65 





Question 14: Please rate current levels of communication between working 
groups. 




Frequent 9.4% 15 
Periodic 24.4% 39 
Limited 33.8% 54 
Very limited 20.6% 33 
Do not know 11.9% 19 
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Please explain 39 











Question 15: What three recommendations would you give to improve communication 
between working groups? 
Answer Options Response Percent  
Recommendation #1 99.4%  
Recommendation #2 80.6%  
















Question 16: Please describe the current levels of communication between 
working groups & the Partners Forum and/or Coordinating Board? 
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Answer Options Response Percent Response 
Count 
Frequent 3.8% 6 
Periodic 25.6% 41 
Limited 28.8% 46 
Very limited 16.3% 26 
Do not know 25.6% 41 
Please explain 37 

















Question 17: Please describe the current level of communication between working 
groups & the Stop TB Partnership’s Secretariat.  
Answer Options Response Percent Response 
Count 
Frequent 15.6% 25 
Periodic 25.0% 40 
Limited 24.4% 39 
Very limited 9.4% 15 
Do not know 25.6% 41 
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Please explain 34 







Question 18: What are the main ways in which your working group (or sub-group) 
currently reviews & evaluates i ts progress? Select no more than three. 
Answer Options Response Percent Response 
Count 
Agenda item for discussion in meetings 54.1% 79 
Surveys/questionnaires 26.0% 38 
Report to the Partners Forum and/or Coordinating Board 33.6% 49 
Annual review & report for internal use 38.4% 56 
Annual review & report for external use 14.4% 21 
Review by Stop TB Secretariat 18.5% 27 
Independent external evaluation 8.2% 12 
My working group (or sub-group) does not currently 
review & evaluate progress 
19.2% 28 
Other (please specify) 25 















Question 19: What addit ional resources or support would you need in order to 
improve review and evaluation of your working group (or sub-group)? 
Answer Options Response Percent Response 
Count 
Additional funding 63.8% 102 
Additional WHO/Stop TB staff time 33.1% 53 
Training in review & evaluation 45.6% 73 
Guidelines from the Stop TB 
Partnership Secretariat 
54.4% 87 
Other (please specify) 29 











Question 20: What three recommendations would you make to improve the 
overal l  eff ic iency and effectiveness of working groups (and sub-groups)?  
Answer Options Response Percent Response 
Count 
Recommendation #1 100.0% 160 
Recommendation #2 79.4% 127 
Recommendation #3 65.6% 105 
answered question 160 
Recommendations focused on funding primarily, but covered a broad range of issues and impacts addressed 
in the survey ranging from participation, roles and responsibilities, leadership and group structures.  
Key Recommendations: 
• Funding as some groups are currently working independently without funds from The Stop TB 
Partnership. 
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• Ensure a dedicated staff member for each group. 
• Improve alignment between budget and WG agendas. 
• There needs to be greater incentive for partners to participate. 
• Implement official membership registration to make sure participants are active. 
• Assign roles to the core groups with responsibility for communicating. 
• “Members should dedicate time to be fully engaged in the group. Offer different level of participation: 
active participant (core team member and need to be at all meetings and on all calls), semi‐active 
participants (some meetings and calls), and non active participants (can review updates on the website 
and post comments and questions)” 
• “Condense the Working Groups into 4 which are focussed on approaches: Health Systems Strengthening, 
Empowering Patients and Communities, Engaging all Health Care Providers, Research” 
6.8 Review of Follow‐up on 2008 McKinsey Recommendations 
In 2008, the Stop TB Partnership commissioned McKinsey to conduct an independent evaluation of the 
Partnership. As part of this evaluation, the final report laid out a series of recommendations specifically 
related to the Working Groups. These recommendations are presented on pages 63‐65 of the report under 
‘Recommendation 7’.  
As part of the current review, TPI was asked to analyze the extent to which the McKinsey’s 
recommendations have been implemented or acted upon. Based on the interview and survey results as well 
as desk research from the website and the internal 2011 Analysis of Stop TB Partnership Working Groups, 
the following chart summarizes TPI’s findings.  
Recommendation 7: 
“The Partnership should continue to use Working Groups as a major vehicle contributing to TB 
control and research, systematize the processes for their establishment and performance review, 
and provide them support from the Secretariat.” 
Specific McKinsey Recommendations  2011 Status of Implementation 
7.1a Establishment:  
“The Coordinating Board should establish 
Working Groups on selected strategic 
topics for a fixed duration of 3 years, and 
review these every 3 years, starting with 
the May 2008 Coordinating Board.  
Exhibit 33 lays out proposed selection 
criteria for Working Groups and 
alternative mechanisms for addressing 
strategic issues.” 
Partially achieved 
The current review by TPI as well as the 
formation of the time‐limited Task Force 
on WGs three years after the McKinsey 
study shows a commitment to review WGs 
every three years. While the current 
review partially addresses the issue of 
working composition, there is neither 
evidence of a Coordinating Board strategic 
prioritisation process nor the 
establishment of selection criteria by 
which the CB can systematically review 
WGs and their issue focus. 
7.1b Number of Groups 
“Given the complexity of the issues 
Partially achieved 
While there are currently only 7 WGs, 
 61 
 
requiring a Working Group approach, our 
view is that the total number of Working 
Groups should ideally not be more than 7 
‐ 8, to ensure that the Partnership as a 
whole and the Coordinating Board in 
particular can devote sufficient time and 
energy to each.  If there are more than 
eight issues that meet the criteria for WG 
status, the Coordinating Board should 
debate and prioritize the 7 ‐ 8 that are 
most critical over the 3‐year period, and 
review after 3 years.”  
there is no evidence that a process yet 
exists for the Coordinating Board to 
prioritize WGs in the case that more WGs 
are proposed.  
 
7.1c ACSM WG 
“The Partnership should in this context 
review the status and objectives of the 
ACSM WG:  The Partnership Secretariat 
carries out advocacy and communication 
for TB, particularly at a global level, and 
the other Working Groups, product 
development partnerships, and individual 
Partners do so for their own areas of 
focus.  The Secretariat and ACSM WG 
should work together to ensure that 
there is no duplication of activities, either 
by developing a remit for the WG that is 
consistent with the establishment criteria 
above and clearly non‐duplicative, or by 
absorbing the WG activities into the 
Secretariat Advocacy Unit and the 
Coordinating Board subcommittee on 
Advocacy (see Recommendation 9)” 
Achieved 
The status of the ACSM WG has been 
discussed within The Secretariat and the 
decision was taken to disband the ACSM 
WG and to incorporate ACSM activities 
within other WGs. 
7.2 Review:  
“The Coordinating Board should review 
the impact, effectiveness, and efficiency 
of all WGs every 3 years, and address the 
following:  
Existence:  Dissolve WGs that no longer 
meet establishment criteria (e.g., because 
they have successfully addressed the 
issues they were created for) 
Performance: Assess how well and how 
efficiently each Working Group has 
delivered against its internal objectives, 
and make necessary recommendations on 
Not achieved 
While the Coordinating Board reviews 
individual WGs on an adhoc basis, it is not 
clear that the CB has a process in place to 
systematically review the impact, 
effectiveness and efficiency of all WGs 
every 3 years.  
Existence: The Coordinating Board has 
dissolved WGs in the past (e.g. ACSM), 
however interviewees suggested that 
there is neither a common process nor 
specific criteria for doing so. 
Performance: While the Coordinating 
Board reviews each WG’s workplan, 
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how to improve performance  
Membership and leadership:  Review the 
appropriateness of Working Group broad 
membership and core membership.  
Rotate the Chair, unless there is a very 
compelling reason to maintain the Chair 
for a second 3‐year term” 
interviewees and survey responses noted 
a lack of feedback to WGs on how they 
can enhance performance as a critical area 
for improvement. 
Membership and leadership: Most WGs 
have in place a process to rotate a Chair, 
but there is a lack of consistency between 
WGs and there is no indication that the 
Coordinating Board plays any role in 
managing the process.  
7.3 Activities:  
“All Working Groups should serve as 
topic‐specific forums for discussion and 
debate, which Partners can use to inform 
their own activities. Each Working Group 
should also prepare:  
• A 3‐year strategic plan laying out the 
external goals it is targeting, the specific 
internal goals, deliverables (e.g., reports, 
draft guidance, endorsement statements), 
and milestones it is voluntarily setting itself, 
the main activities involved, and the 
resources and funding required  
• A more detailed annual operational plan 
• An annual performance report vs. the 
operating plan  
The Partnership Secretariat, in 
consultation with WG Chairs, should 
prepare templates for the strategic plan 
and operational plan and for the annual 
report. Each WG should publish its 
strategic plan to increase transparency, 
encourage cooperation, and incentivize 
accountability.” 
Partially achieved 
Interviewees noted that WGs put together 
annual strategic plans but not the 3‐year 
strategic plans recommended by 
McKinsey. 
Interviewees noted that while WGs submit 
performance reports, there is not a 
standard process for doing so. 
Additionally, some interviewees noted 
that performance reports tend to 
emphasize action items or activities as 
opposed to outputs and accomplishments 
as recommended by the McKinsey review. 
7.4 Funding:  
Working Groups should be established 
with a funding plan.  This would call for 
use of existing Partnership funds, or 
funds or donations‐in‐kind directly 
contributed by Partners.  Working Groups 
should also identify where they need 
Partnership Secretariat or broader 
Partnership support in raising necessary 
funds.  They should report on use of 
Partially achieved 
WGs submit requests for funding from the 
Stop TB Secretariat, however they are not 
required to provide an account of how and 
from where additional external funds are 
raised. This point was reiterated in the 
March 2011 ‘Analysis of Stop TB 
Partnership Working Groups’, which 
showed that many WGs had not full 
declared all of their funding and sources 
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funds in their annual performance report   to the Stop TB Secretariat.   
7.5 Administrative support:   
“Working Groups should have dedicated 
administrative support, detailed in their 
Operating Plans, with funding or 
resourcing ideally provided by WG 
Partners themselves.  The Partnership 
Secretariat should provide funding 
adequate for a baseline level of 
administrative support (e.g., 0.5FTE per 
Working Group) and could consider 
further funding support based on the WG 
Operating Plans.” 
Partially achieved 
While all WGs have some level of 
administrative support provided by the 
Partnership, interviews and surveys 
showed that many were not satisfied with 
the level of support. In general, the 
Partnership currently provides 0.15 FTE 
per WG, which is not considered to be 
adequate to meet WG needs. Nonetheless 
some WGs have supplemented the 
support provided by the Partnership by 
securing external funding.   
7.6 Performance transparency:  
“Working Groups should review their 
performance against their Strategic and 
Operating Plans, and make these visible 
to the Coordinating Board. We 
recommend that Working Groups review 
their performance with the Working 
Group sub‐committee of the CB every 6 
months for informal feedback and joint 
problem‐solving.  These meetings should 
be attended by all Working Group Chairs 
and Secretaries and the Executive 
Secretary, and also serve to identify and 
manage potential synergies and 
duplications among Working Groups. The 
Working Group sub‐committee should 
then report on Working Groups’ 
performance to the Board every year.” 
Not achieved 
Interviews and the survey suggest that 
WGs are not yet formally required to 
review performance with Coordinating 
Board sub‐committee every six months as 
recommended by McKinsey. 
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